Attenuating effects of Azanza garckeana fractions on glycemo-impaired-associated dyslipidemia, hepatopathy, and nephropathy

Authors
Category Primary study
JournalAmerican Journal of Translational Research
Year 2023
This article has no abstract
Epistemonikos ID: 6c42532941b2d9f886d8b6782564f2d30f68d73c
First added on: Jun 13, 2024